Influenza vaccines: The virosome concept

Immunology Letters

Volumn 122, Issue 2, 2009, Pages 118-121

  Wilschut, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antibody; Antigen presenting cells; CTL; Cytotoxic T cell; Influenza vaccine; Virosome

Indexed keywords

GLYCOPROTEIN; HEMAGGLUTININ; HEPATITIS A VACCINE; IMMUNOGLOBULIN RECEPTOR; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIROSOME VACCINE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIROSOME;

ADJUVANT THERAPY; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; B LYMPHOCYTE; CELL FUSION; CELL INTERACTION; CELL MATURATION; CELLULAR IMMUNITY; CEREBROVASCULAR DISEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; HEART DISEASE; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THERAPY EFFECT; VIRUS ENTRY; VIRUS PNEUMONIA; ANIMAL; ANTIBODY PRODUCTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFECTION CONTROL; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1;

ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; COMMUNICABLE DISEASE CONTROL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, VIROSOME; VIROSOMES;

EID: 73349125483     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.11.007     Document Type: Review

References (10)

1. J.C. Wilschut J.M. McElhaney A.M. Palache Rapid reference influenza 2nd ed. 2006 Mosby–Elsevier Science London p. 1–240
2. K.G. Nicholson J.M. Wood M. Zambon Influenza Lancet 362 2003 1733 1745
3. K. Stöhr The global agenda on influenza surveillance and control Vaccine 21 2003 1748 1774
4. K.L. Nichol The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines Vaccine 21 2003 1769 1775
5. A.E. Smith A. Helenius How viruses enter animal cells Science 304 2004 237 242
6. A. Huckriede L. Bungener T. Stegmann T. Daemen J. Medema A.M. Palache The virosome concept for influenza vaccines Vaccine 23S1 2005 S1/26–S1/38
7. T. Stegmann H.W. Morselt F.P. Booy J.F. Van Breemen G. Scherphof J. Wilschut Functional reconstitution of influenza virus envelopes EMBO J 6 1987 2651 2659
8. L.B. Bungener K. Serre M. Kraak L. Bijl L. Leserman J. Wilschut Virosome-mediated delivery of protein antigens to dendritic cells Vaccine 20 2002 2287 2295
9. L. Bungener A. Huckriede A. de Mare J. de Vries-Idema J. Wilschut T. Daemen Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity Vaccine 23 2005 1232 1241
10. I. Leroux-Roels A. Borkowski T. Vanwolleghem M. Dramé F. Clement J.M. Devaster Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial The Lancet 370 2007 580 589